These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 23469749)

  • 21. [Impact of predictive models and decision making in prostate cancer: An integral debate].
    Gómez Veiga F; Ponce Díaz-Reixa J; Pértega Díaz S; Martínez Breijo S; Gonzalez Dacal J; Andraca AZ; Nebra JC; García DL; Fernández SP; Abal VC
    Arch Esp Urol; 2011 Oct; 64(8):765-82. PubMed ID: 22052758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defining high risk prostate cancer with risk groups and nomograms: implications for designing clinical trials.
    Roach M; Weinberg V; Nash M; Sandler HM; McLaughlin PW; Kattan MW
    J Urol; 2006 Dec; 176(6 Pt 2):S16-20. PubMed ID: 17084158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combining the cost of reducing uncertainty with the selection of risk assessment models for remediation decision of site contamination.
    Chen YC; Ma HW
    J Hazard Mater; 2007 Mar; 141(1):17-26. PubMed ID: 16926066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction tools in surgical oncology.
    Isariyawongse BK; Kattan MW
    Surg Oncol Clin N Am; 2012 Jul; 21(3):439-47, viii-ix. PubMed ID: 22583992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The San Francisco Syncope Rule vs physician judgment and decision making.
    Quinn JV; Stiell IG; McDermott DA; Kohn MA; Wells GA
    Am J Emerg Med; 2005 Oct; 23(6):782-6. PubMed ID: 16182988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer.
    Chun FK; Karakiewicz PI; Briganti A; Walz J; Kattan MW; Huland H; Graefen M
    BJU Int; 2007 Apr; 99(4):794-800. PubMed ID: 17378842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How to build and interpret a nomogram for cancer prognosis.
    Iasonos A; Schrag D; Raj GV; Panageas KS
    J Clin Oncol; 2008 Mar; 26(8):1364-70. PubMed ID: 18323559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ.
    Rudloff U; Jacks LM; Goldberg JI; Wynveen CA; Brogi E; Patil S; Van Zee KJ
    J Clin Oncol; 2010 Aug; 28(23):3762-9. PubMed ID: 20625132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive-emotional decision making (CEDM): a framework of patient medical decision making.
    Power TE; Swartzman LC; Robinson JW
    Patient Educ Couns; 2011 May; 83(2):163-9. PubMed ID: 20573468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk assessment in the management of patients with ocular hypertension.
    Weinreb RN; Friedman DS; Fechtner RD; Cioffi GA; Coleman AL; Girkin CA; Liebmann JM; Singh K; Wilson MR; Wilson R; Kannel WB
    Am J Ophthalmol; 2004 Sep; 138(3):458-67. PubMed ID: 15364230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Models for risk assessment and prediction in breast cancer].
    Hu Z; Li X; Feng MH; Chu JJ; Xie W
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Oct; 30(10):1073-7. PubMed ID: 20193393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decision making process: problem-based decision making.
    Shedid D; Benzel EC
    Neurosurgery; 2007 Jan; 60(1 Supp1 1):S166-9. PubMed ID: 17204880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An overview on cognitive aspects implicated in medical decisions.
    Gorini A; Pravettoni G
    Eur J Intern Med; 2011 Dec; 22(6):547-53. PubMed ID: 22075278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence of an internecine conflict within the practice of environmental risk assessment?
    Bridges TS; Glaser D
    Integr Environ Assess Manag; 2008 Apr; 4(2):138. PubMed ID: 18494115
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prognostic factors of localised, locally advanced or metastatic prostate cancer].
    Joly F; Henry-Amar M
    Bull Cancer; 2007 Jul; 94(7 Suppl):F35-43. PubMed ID: 17845992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous endoscopic gastrostomy (PEG): the role and perspective of nurses.
    Todd V; Van Rosendaal G; Duregon K; Verhoef M
    J Clin Nurs; 2005 Feb; 14(2):187-94. PubMed ID: 15669927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk perception and communication.
    Greenberg M; Lowrie K
    Risk Anal; 2009 Aug; 29(8):1059-60. PubMed ID: 19659546
    [No Abstract]   [Full Text] [Related]  

  • 38. And so we model: the ineffective use of mathematical models in ecological risk assessments.
    Tannenbaum LV
    Integr Environ Assess Manag; 2007 Oct; 3(4):473-5. PubMed ID: 18046795
    [No Abstract]   [Full Text] [Related]  

  • 39. Are nomograms needed in the management of bladder cancer?
    Nguyen CT; Stephenson AJ; Kattan MW
    Urol Oncol; 2010; 28(1):102-7. PubMed ID: 20123358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative theories for clinical decision making.
    Habbema JD
    Rev Epidemiol Sante Publique; 1984; 32(3-4):172-80. PubMed ID: 6522731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.